On 11 Apr. 2022, the European Commission has added 5 substances into the Authorised List by adopting the Commission Regulation COMMISSION REGULATION (EU) 2022/586 of 8 April 2022 regarding amending Annex XIV to REACH Regulation. This amendments will take effect from 1 May 2022.
So far, a total of 59 substances are subject to authorization.
The newly added entries are as follows:
Entry Nr | Substance | Intrinsic property(ies) referred to in Article 57 | Transitional arrangements | Exempted (categories of) uses | Review periods | |
Latest application date(1) | Sunset date(2) | |||||
‘55. | Tetraethyllead EC No: 201-075-4 CAS No: 78-00-2 | Toxic for reproduction (category 1A) | 1 November 2023 | 1 May 2025 | - | - |
56. | 4,4'-bis(dimethylamino)-4"-(methylamino)trityl alcohol (with ≥ 0,1 % of Michler’s ketone (EC No 202-027-5) or Michler’s base (EC No 202-959-2)) EC No: 209-218-2 CAS No: 561-41-1 | Carcinogenic (category 1B) | 1 November 2023 | 1 May 2025 | - | - |
57. | Reaction products of 1,3,4-thiadiazolidine-2,5-dithione, formaldehyde and 4-heptylphenol, branched and linear (RP-HP) (with ≥ 0,1 % w/w 4-heptylphenol, branched and linear) EC No: - CAS No: - | Endocrine disrupting properties (Article 57, point (f) – environment) | 1 November 2023 | 1 May 2025 | - | - |
58. | 2-ethylhexyl 10-ethyl-4,4-dioctyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoate (DOTE) EC No: 239-622-4 CAS No: 15571-58-1 | Toxic for reproduction (category 1B) | 1 November 2023 | 1 May 2025 | - | - |
59. | Reaction mass of 2-ethylhexyl 10-ethyl-4,4-dioctyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoate and 2-ethylhexyl 10-ethyl-4-[[2-[(2-ethylhexyl)oxy]-2-oxoethyl]thio]-4-octyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoate (reaction mass of DOTE and MOTE) EC No: - CAS No: - | Toxic for reproduction (category 1B) | 1 November 2023 | 1 May 2025 | - | -’ |
CIRS C&K Testing warmly reminds that these substances cannot be placed on the market or used after the sunset date, unless an authorisation is granted for their specific use, or the use is exempted from Authorisation.
If you have any needs or questions, please contact us at test@cirs-group.com.
Further Information
Contact Us
Quick Navigation